Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal.
about
Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damageImmune dysfunction in uremia—an updateThe Gut as a Source of Inflammation in Chronic Kidney DiseaseIndomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysisLevel of inflammatory factors in chronic hemodialysis patients with and without cardiovascular disease.Glycemic load is associated with oxidative stress among prevalent maintenance hemodialysis patientsAlteration of the gut microbiota in Chinese population with chronic kidney diseaseIL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survivalDecrease in urinary creatinine excretion in early stage chronic kidney disease.IL-1β receptor antagonist reduces inflammation in hemodialysis patientsSoluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survivalThe uremic toxin indoxyl sulphate enhances macrophage response to LPS.Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patientsAlterations of intestinal barrier and microbiota in chronic kidney disease.Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal diseaseLow T3 syndrome and long-term mortality in chronic hemodialysis patientsLow-grade inflammation, metabolic syndrome and the risk of chronic kidney disease: the 2005 Korean National Health and Nutrition Examination Survey.Chronic Inflammation and Coronary Atherosclerosis in Patients with End-Stage Renal DiseaseA reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression.Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients.Cholesterol Metabolism in CKDAssociation between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients.Mediterranean diet, kidney function, and mortality in men with CKD.Circulating chemokine ligand levels before and after successful kidney transplantationPlasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis.Predialysis chronic kidney disease in 2010: Novel targets for slowing CKD progression.Monitoring of inflammation in patients on dialysis: forewarned is forearmed.Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.Dialysis in 2011: Can cardiovascular risk in dialysis patients be decreased?Associations of physical activity energy expenditure with nutritional-inflammatory markers in hemodialysis patients.Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.C-reactive protein variability is associated with vascular access outcome in hemodialysis patients.Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.Cardiovascular disease in haemodialysis: role of the intravascular innate immune system.Inflammation and premature aging in advanced chronic kidney disease.Impact of serum and dialysates obtained from chronic hemodialysis patients maintained on high cut-off membranes on inflammation profile in human THP-1 monocytes.Dual PPAR α / γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia.Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice.
P2860
Q26770744-FF520AC8-68C0-4E66-B508-A1CC1164BD00Q26829076-94B71CC7-589E-4B2B-9DBA-370844EFD8EBQ28081781-1819F1EB-1E85-4566-8064-FC01B1F2A182Q28729196-6D8BE8FC-EAE1-4BE1-AF76-42074411E68CQ33660722-BB981818-1412-4060-B2AE-9E0901B6884FQ33749291-F9AE86E0-6D84-4235-8225-C5323E96B3F8Q33767631-E37CA3BF-69EB-480B-9D11-E6C8A6820934Q33797359-30BA39B4-4A6B-49EE-A442-7F9D229E6EB0Q34523616-B9215B02-11B2-4AEA-BEC4-334AC854EE73Q34695324-9FB0A56B-86F8-46D5-ABFC-95D0F630B7F8Q34751855-DD06DBE9-901F-4A47-B4C9-9B483E95EAD3Q34926791-942F67A2-DB70-4979-9C15-AC9EDEAB697DQ35010395-BD23CCB6-2191-4B3E-A124-D3122DCE113FQ35227582-DEA29BC7-EC5E-4AAA-AE96-6FA9256CDED2Q35239148-564A5589-067B-4E1A-939A-378A98E36E4AQ35664554-EED3B827-5E18-46C9-97B5-1A9181741D20Q35819441-D18457DB-5334-47E5-9129-C91275664716Q36014454-B0BBC933-0BD2-4ABC-AA7B-29E8D6A0F3B3Q36036008-C7B6A213-6286-425A-A123-CF5E6B85F3B6Q36081100-15E40928-96FA-45D9-9774-6F9905B65C58Q36126923-E3184271-87A0-4B6F-98E1-065FF4C17941Q36315574-44675FC3-0C45-4459-9980-07BF53E0140BQ36443224-2433BFE4-F1A7-4A08-B477-29F6C04A3F9AQ36849215-D5F73DC5-5714-4C53-9A40-80686E7DBE81Q37246956-CABEB38D-E0EE-44A2-B181-0841364531E3Q37369596-C859ADD5-AA71-4975-B837-DB8335090129Q37600685-427F0DB4-56AE-4C9C-9B0A-9C43A38EC06BQ37833470-AE142256-71F5-4CDA-AE40-DBC4D2E74EDAQ37848040-434F5FCF-7986-4F8A-A4C2-61DF63A54D79Q37871569-539101BC-68E1-487A-B059-AD4DFDE33204Q37967084-062C0A70-CB65-4A29-A6FE-709E706248A4Q38598026-468E37AC-7B24-4D7A-A183-F92E8D11C527Q38636372-B993E0F4-F32A-43B0-AD60-DBEF3796D196Q38816561-59D5E446-D574-4472-928A-E2730F8DB0A0Q38921854-B8B8265A-EE20-4914-A442-CA1DDBDBAB25Q39151839-F03557DC-D8EB-4A53-B8AE-6293AFC1BF49Q39309490-BC7E9D0A-49DD-48E0-A40C-AB13028E47BAQ39349865-80E84F5D-5289-41EC-A516-2DC4BABB722BQ39826326-CBD200E9-C452-44AF-8861-B28C94D80820Q40188954-D2B8727E-3918-45C4-8455-5B81CDFC4592
P2860
Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Persistent inflammation as a c ...... isease: a hypothesis proposal.
@en
Persistent inflammation as a c ...... isease: a hypothesis proposal.
@nl
type
label
Persistent inflammation as a c ...... isease: a hypothesis proposal.
@en
Persistent inflammation as a c ...... isease: a hypothesis proposal.
@nl
prefLabel
Persistent inflammation as a c ...... isease: a hypothesis proposal.
@en
Persistent inflammation as a c ...... isease: a hypothesis proposal.
@nl
P356
P1476
Persistent inflammation as a c ...... isease: a hypothesis proposal.
@en
P2093
Juan Jesús Carrero
P304
P356
10.2215/CJN.02720409
P478
P577
2009-12-01T00:00:00Z